Erasca, Inc. (ERAS)
14.66
-0.84
(-5.42%)
USD |
NASDAQ |
Mar 12, 16:00
14.70
+0.04
(+0.27%)
After-Hours: 20:00
Erasca EPS Diluted (Quarterly) : -0.1079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -0.2945 |
| Revolution Medicines, Inc. | -1.855 |
| AbbVie, Inc. | 1.018 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Incyte Corp. | 1.462 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.61M |
| Total Expenses (Quarterly) | 30.61M |
| Enterprise Value | 4.558B |
| Earnings Yield | -3.08% |
| Normalized Earnings Yield | -2.915 |